Diabetes Care Leap: Novo Nordisk launched Awiqli (insulin icodec), the world’s first once-weekly basal insulin in India, aiming to cut insulin injections from 365 to 52 and tackle delayed insulin starts driven by fear and cost. Drug Supply Shock: Reuters reports Dr Reddy’s will delay semaglutide commercial supplies after batches were found “out of specification” for the active ingredient, raising concerns for India’s fast-growing obesity/diabetes market. Primary Healthcare Training: MoHFW ran a national “training of trainers” for all cadres delivering primary care at Ayushman Arogya Mandirs, with cascade rollout planned from August 2026. Hospital Safety Under Scrutiny: A Thane doctor accused of assault fears for his safety and resigns after an alleged attack linked to NICU capacity disputes; Maharashtra doctors also staged black-ribbon protests. Food Safety Crackdown (Mumbai): Maharashtra FDA suspended the licence of K Rustom & Co ice cream parlour after finding rats, flies, expired items and cold-chain lapses. Climate & Health Risks: IMD warned of heavy rain and strong winds in Mumbai and nearby districts, while a study estimates early menopause affects 1 in 14 women (30-49) in low- and middle-income countries. Public Health Access Gap: A Delhi government cancer hospital report highlights long waits for tests and an idle Rs 15 crore machine. Medtech Growth Outlook: Bain projects India’s medtech opportunity could reach $35 billion by 2030.